Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Björn Walse is active.

Publication


Featured researches published by Björn Walse.


Structure | 2002

Crystal structure of a SEA variant in complex with MHC class II reveals the ability of SEA to crosslink MHC molecules.

Karin Petersson; Marjolein Thunnissen; Göran Forsberg; Björn Walse

Although the biological properties of staphylococcal enterotoxin A (SEA) have been well characterized, structural insights into the interaction between SEA and major histocompatibilty complex (MHC) class II have only been obtained by modeling. Here, the crystal structure of the D227A variant of SEA in complex with human MHC class II has been determined by X-ray crystallography. SEA(D227A) exclusively binds with its N-terminal domain to the alpha chain of HLA-DR1. The ability of one SEA molecule to crosslink two MHC molecules was modeled. It shows that this SEA molecule cannot interact with the T cell receptor (TCR) while a second SEA molecule interacts with MHC. Because of its relatively low toxicity, the D227A variant of SEA is used in tumor therapy.


Journal of Immunology | 2007

Cutting Edge: Evidence of Direct TCR α-Chain Interaction with Superantigen

Nick Pumphrey; Annelise Vuidepot; Bent K. Jakobsen; Göran Forsberg; Björn Walse; Karin Lindkvist-Petersson

Superantigens are known to activate a large number of T cells. The SAg is presented by MHC class II on the APC and its classical feature is that it recognizes the variable region of the β-chain of the TCR. In this article, we report, by direct binding studies, that staphylococcal enterotoxin (SE) H (SEH), a bacterial SAg secreted by Staphylococcus aureus, instead recognizes the variable α-chain (TRAV27) of TCR. Furthermore, we show that different SAgs (e.g., SEH and SEA) can simultaneously bind to one TCR by binding the α-chain and the β-chain, respectively. Theoretical three-dimensional models of the penta complexes are presented. Hence, these findings open up a new dimension of the biology of the staphylococcal enterotoxins.


Archive | 2001

Engineered superantigen for human therapy

Göran Forsberg; Eva Erlandsson; Per Antonsson; Björn Walse


Archive | 2006

Methods for treating a subject having cancer by the administration of a conjugate between a variant staphylococcal entertoxin E superantigen and an antibody that binds to the 5T4 antigen

Göran Forsberg; Eva Erlandsson; Per Antonsson; Björn Walse


Archive | 2002

Novel engineered superantigen for human therapy

Göran Forsberg; Eva Erlandsson; Per Antonsson; Björn Walse


Archive | 2002

A novel engineered superantigen for human therapy

Göran Forsberg; Eva Erlandsson; Per Antonsson; Björn Walse


Archive | 2017

Nýr tilbúinn fjölræsivaki til að nota við meðferð á manneskjum

Göran Forsberg; Eva Erlandsson; Per Antonsson; Björn Walse


Archive | 2013

Specific Expansion of T Cells α Staphylococcal Enterotoxin H Induces V

Björn Walse; Göran Forsberg; Karin Petersson; Helen M. Pettersson; Niels Jörgen Skartved


Archive | 2009

Conjugates between a variant staphylococcal enterotoxin e superantigen and a targeting antibody that binds to a cancer-associated cell surface structure

Göran Forsberg; Eva Erlandsson; Per Antonsson; Björn Walse


Archive | 2002

Superantigene modifie genetiquement pour therapie humaine

Göran Forsberg; Eva Erlandsson; Per Antonsson; Björn Walse

Collaboration


Dive into the Björn Walse's collaboration.

Top Co-Authors

Avatar

Göran Forsberg

Cooperative Research Centre

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Göran Forsberg

Cooperative Research Centre

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge